dihydropteridine reductase |
leukemias |
Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? |
10706461 |
Human |
dihydropteridine reductase |
lymphomas |
Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? |
10706461 |
Human |
dihydropteridine reductase |
leukemias |
Urinary neopterin levels, blood dihydropteridine reductase activity as well as other frequently used clinical parameters were evaluated in 110 patients suffering from various types of lymphomas and leukemias. |
10706461 |
Human |
dihydropteridine reductase |
lymphomas |
Urinary neopterin levels, blood dihydropteridine reductase activity as well as other frequently used clinical parameters were evaluated in 110 patients suffering from various types of lymphomas and leukemias. |
10706461 |
Human |
dhpr |
haematological malignancies |
Our data also suggest that reductions in DHPR activities may also be an underlying cause for the neurological disorders that are commonly seen in patients with haematological malignancies. |
10706461 |
Human |
dihydropteridine reductase |
mastocytoma |
NADH-specific dihydropteridine reductase in mastocytoma P-815 cells. |
6434226 |
Human |
dihydropteridine reductase |
mastocytoma |
NADH-specific dihydropteridine reductase [EC 1.6.99.7] was purified from mouse mastocytoma P-815 cells. |
6434226 |
Human |
dihydropteridine reductase |
neoplasms |
The undifferentiated enzymic composition of neoplasms is reflected by the lower dihydropteridine reductase content of pulmonary tumors than of nonneoplastic human lung. |
710385 |
Human |
dihydropteridine reductase |
tumors |
The undifferentiated enzymic composition of neoplasms is reflected by the lower dihydropteridine reductase content of pulmonary tumors than of nonneoplastic human lung. |
710385 |
Human |
dihydropteridine reductase |
neuroblastoma |
Neuroblastoma in a patient with dihydropteridine reductase deficiency. |
2209664 |
Human |
dihydropteridine reductase |
acute lymphoblastic leukemia |
Hyperphenylalaninemia caused by dihydropteridine reductase deficiency in children receiving chemotherapy for acute lymphoblastic leukemia. |
2795366 |
Human |
dihydropteridine reductase |
neurofibromatosis |
Other conditions associated with calcification were Sturge-Weber syndrome, neurofibromatosis, Cockayne's syndrome, hypoparathyroidism, arteriovenous malformations, vein of Galen aneurysm, encephalomalacia, cerebral infarcts, subdural hematoma, cerebr |
8016912 |
Human |
dihydropteridine reductase |
arteriovenous malformations |
Other conditions associated with calcification were Sturge-Weber syndrome, neurofibromatosis, Cockayne's syndrome, hypoparathyroidism, arteriovenous malformations, vein of Galen aneurysm, encephalomalacia, cerebral infarcts, subdural hematoma, cerebr |
8016912 |
Human |
dihydropteridine-reductase |
breast cancer |
Dihydropteridine-reductase activity in breast cancer. |
6266525 |
Human |
dihydropteridine-reductase |
breast cancers |
Preliminary report. The dihydropteridine-reductase activity was measured in 206 breast cancers. |
6266525 |
Human |